Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice

References

• Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 2004; 5:292 - 302; http://dx.doi.org/10.1016/S1470-2045(04)01467-6; PMID: 15120666
   PubMed Web of Science ®Google Scholar
• Dalle S, Thieblemont C, Thomas L, Dumontet C. Monoclonal antibodies in clinical oncology. Anticancer Agents Med Chem 2008; 8:523 - 32; http://dx.doi.org/10.2174/187152008784533071; PMID: 18537534
   PubMed Web of Science ®Google Scholar
• Hudis CA. Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med 2007; 357:39 - 51; http://dx.doi.org/10.1056/NEJMra043186; PMID: 17611206
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177 - 82; http://dx.doi.org/10.1126/science.3798106; PMID: 3798106
   PubMed Web of Science ®Google Scholar
• Lan KH, Lu CH, Yu D. Mechanisms of trastuzumab resistance and their clinical implications. Ann N Y Acad Sci 2005; 1059:70 - 5; http://dx.doi.org/10.1196/annals.1339.026; PMID: 16382045
   PubMed Web of Science ®Google Scholar
• Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495 - 7; http://dx.doi.org/10.1038/256495a0; PMID: 1172191
   PubMed Web of Science ®Google Scholar
• Sgro C. Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review. Toxicology 1995; 105:23 - 9; http://dx.doi.org/10.1016/0300-483X(95)03123-W; PMID: 8638282
   PubMed Web of Science ®Google Scholar
• Khazaeli MB, Conry RM, LoBuglio AF. Human immune response to monoclonal antibodies. J Immunother Emphasis Tumor Immunol 1994; 15:42 - 52; http://dx.doi.org/10.1097/00002371-199401000-00006; PMID: 8110730
   PubMed Web of Science ®Google Scholar
• Hwang WY, Foote J. Immunogenicity of engineered antibodies. Methods 2005; 36:3 - 10; http://dx.doi.org/10.1016/j.ymeth.2005.01.001; PMID: 15848070
   PubMed Web of Science ®Google Scholar
• Brüggemann M, Winter G, Waldmann H, Neuberger MS. The immunogenicity of chimeric antibodies. J Exp Med 1989; 170:2153 - 7; http://dx.doi.org/10.1084/jem.170.6.2153; PMID: 2584938
   PubMed Web of Science ®Google Scholar
• Mirick GR, Bradt BM, Denardo SJ, Denardo GL. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Q J Nucl Med Mol Imaging 2004; 48:251 - 7; PMID: 15640788
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Tsumoto K, Yokota A, Kondo H, Kumagai I. Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10. Protein Sci 2008; 17:261 - 70; http://dx.doi.org/10.1110/ps.073156708; PMID: 18227432
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Maru T, Tahara K, Sanada H, Umetsu M, Asano R, Kumagai I. Development of an affinity-matured humanized anti-epidermal growth factor receptor antibody for cancer immunotherapy. Protein Eng Des Sel 2013; 26:113 - 22; http://dx.doi.org/10.1093/protein/gzs088; PMID: 23118340
   PubMed Web of Science ®Google Scholar
• Queen C, Schneider WP, Selick HE, Payne PW, Landolfi NF, Duncan JF, Avdalovic NM, Levitt M, Junghans RP, Waldmann TA. A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A 1989; 86:10029 - 33; http://dx.doi.org/10.1073/pnas.86.24.10029; PMID: 2513570
   PubMed Web of Science ®Google Scholar
• Yoon SO, Lee TS, Kim SJ, Jang MH, Kang YJ, Park JH, Kim KS, Lee HS, Ryu CJ, Gonzales NR, et al. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J Biol Chem 2006; 281:6985 - 92; http://dx.doi.org/10.1074/jbc.M511165200; PMID: 16407221
   PubMed Web of Science ®Google Scholar
• Wege AK, Ernst W, Vollmann-Zwerenz A, Männel DN, Ortmann O, Kroemer A, Brockhoff G. Humanized tumor mice--a new model to study and manipulate the immune response in advanced cancer therapy. Int J Cancer 2011; 129:2194 - 206; http://dx.doi.org/10.1002/ijc.26159; PMID: 21544806
   PubMed Web of Science ®Google Scholar
• Wege AK, Schardt K, Schaefer S, Brockhoff G, Jung EM. High resolution ultrasound including elastography and contrast-enhanced ultrasound (CEUS) for early detection and characterization of liver lesions in the humanized tumor mouse model. Clin Hemorheol Microcirc 2012; 52:93 - 106; PMID: 22975935
   PubMed Web of Science ®Google Scholar
• Brehm MA, Jouvet N, Greiner DL, Shultz LD. Humanized mice for the study of infectious diseases. Curr Opin Immunol 2013; 25:428 - 35; http://dx.doi.org/10.1016/j.coi.2013.05.012; PMID: 23751490
   PubMed Web of Science ®Google Scholar
• Macchiarini F, Manz MG, Palucka AK, Shultz LD. Humanized mice: are we there yet?. J Exp Med 2005; 202:1307 - 11; http://dx.doi.org/10.1084/jem.20051547; PMID: 16301740
   PubMedGoogle Scholar
• Ernst W, Zimara N, Hanses F, Männel DN, Seelbach-Göbel B, Wege AK. Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun 2013; 81:1520 - 31; http://dx.doi.org/10.1128/IAI.01235-12; PMID: 23439310
   PubMed Web of Science ®Google Scholar
• Schmidt M, Micke P, Gehrmann M, Hengstler JG. Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors. Oncoimmunology 2012; 1:1156 - 8; http://dx.doi.org/10.4161/onci.21653; PMID: 23170262
   PubMed Web of Science ®Google Scholar
• Kitchen S, Krutzik S, Levin B, Rezek V, Kitchen C, Zack J. Ligation of CD4 on human blood monocytes triggers macrophage differentiation. J Immunol 2011; 186:158
   Google Scholar
• Tanaka S, Saito Y, Kunisawa J, Kurashima Y, Wake T, Suzuki N, Shultz LD, Kiyono H, Ishikawa F. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J Immunol 2012; 188:6145 - 55; http://dx.doi.org/10.4049/jimmunol.1103660; PMID: 22611244
   PubMed Web of Science ®Google Scholar
• Chen Q, He F, Kwang J, Chan JK, Chen J. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol 2012; 189:5223 - 9; http://dx.doi.org/10.4049/jimmunol.1201789; PMID: 23089398
   PubMed Web of Science ®Google Scholar
• Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A 2009; 106:21783 - 8; http://dx.doi.org/10.1073/pnas.0912274106; PMID: 19966223
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. Blood 2011; 117:3076 - 86; http://dx.doi.org/10.1182/blood-2010-08-301507; PMID: 21252091
   PubMed Web of Science ®Google Scholar
• Nicolini FE, Cashman JD, Hogge DE, Humphries RK, Eaves CJ. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 2004; 18:341 - 7; http://dx.doi.org/10.1038/sj.leu.2403222; PMID: 14628073
   PubMed Web of Science ®Google Scholar
• Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ, Auerbach W, Eynon EE, Stevens S, Manz MG, et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci U S A 2011; 108:2390 - 5; http://dx.doi.org/10.1073/pnas.1019682108; PMID: 21262803
   PubMed Web of Science ®Google Scholar
• Manz MG. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007; 26:537 - 41; http://dx.doi.org/10.1016/j.immuni.2007.05.001; PMID: 17521579
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu CH, Roberts AI, Das J, Xu G, Ren G, Zhang Y, Zhang L, Yuan ZR, Tan HS, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know. Cell Res 2006; 16:126 - 33; http://dx.doi.org/10.1038/sj.cr.7310017; PMID: 16474424
   PubMed Web of Science ®Google Scholar
• Eichbaum C, Meyer AS, Wang N, Bischofs E, Steinborn A, Bruckner T, Brodt P, Sohn C, Eichbaum MH. Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Res 2011; 31:3219 - 27; PMID: 21965729
   PubMed Web of Science ®Google Scholar
• Asano S, Urabe A, Okabe T, Sato N, Kondo Y. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 1977; 49:845 - 52; PMID: 300638
   PubMed Web of Science ®Google Scholar
• Suda T, Miura Y, Mizoguchi H, Kubota K, Takaku F. A case of lung cancer associated with granulocytosis and production of colony-stimulating activity by the tumour. Br J Cancer 1980; 41:980 - 4; http://dx.doi.org/10.1038/bjc.1980.177; PMID: 6968569
   PubMed Web of Science ®Google Scholar
• Shijubo N, Inoue Y, Hirasawa M, Igarashi T, Mori M, Matsuura A, Uede T, Suzuki A. Granulocyte colony-stimulating factor-producing large cell undifferentiated carcinoma of the lung. Intern Med 1992; 31:277 - 80; http://dx.doi.org/10.2169/internalmedicine.31.277; PMID: 1376180
   PubMed Web of Science ®Google Scholar
• Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, Lazennec G. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007; 9:R15; http://dx.doi.org/10.1186/bcr1648; PMID: 17261184
   PubMed Web of Science ®Google Scholar
• Huntington ND, Alves NL, Legrand N, Lim A, Strick-Marchand H, Mention JJ, Plet A, Weijer K, Jacques Y, Becker PD, et al. IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci U S A 2011; 108:6217 - 22; http://dx.doi.org/10.1073/pnas.1019167108; PMID: 21444793
   PubMed Web of Science ®Google Scholar
• De Giovanni C, Nicoletti G, Landuzzi L, Romani F, Croci S, Palladini A, Murgo A, Antognoli A, Ianzano ML, Stivani V, et al. Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. Br J Cancer 2012; 107:1302 - 9; http://dx.doi.org/10.1038/bjc.2012.394; PMID: 22929887
   PubMed Web of Science ®Google Scholar
• Vuyyuru R, Patton J, Manser T. Human immune system mice: current potential and limitations for translational research on human antibody responses. Immunol Res 2011; 51:257 - 66; http://dx.doi.org/10.1007/s12026-011-8243-9; PMID: 22038527
   PubMed Web of Science ®Google Scholar
• Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304:104 - 7; http://dx.doi.org/10.1126/science.1093933; PMID: 15064419
   PubMed Web of Science ®Google Scholar
• Ito R, Shiina M, Saito Y, Tokuda Y, Kametani Y, Habu S. Antigen-specific antibody production of human B cells in NOG mice reconstituted with the human immune system. Curr Top Microbiol Immunol 2008; 324:95 - 107; http://dx.doi.org/10.1007/978-3-540-75647-7_6; PMID: 18481455
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 2005; 106:1565 - 73; http://dx.doi.org/10.1182/blood-2005-02-0516; PMID: 15920010
   PubMed Web of Science ®Google Scholar
• Choi B, Chun E, Kim M, Kim ST, Yoon K, Lee KY, Kim SJ. Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan. J Clin Immunol 2011; 31:253 - 64; http://dx.doi.org/10.1007/s10875-010-9478-2; PMID: 20981478
   PubMed Web of Science ®Google Scholar
• Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, Torrealba J, Burlingham WJ. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum Immunol 2010; 71:551 - 9; http://dx.doi.org/10.1016/j.humimm.2010.02.019; PMID: 20298731
   PubMed Web of Science ®Google Scholar
• Scheeren FA, Nagasawa M, Weijer K, Cupedo T, Kirberg J, Legrand N, Spits H. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J Exp Med 2008; 205:2033 - 42; http://dx.doi.org/10.1084/jem.20070447; PMID: 18695003
   PubMed Web of Science ®Google Scholar
• Becker PD, Legrand N, van Geelen CM, Noerder M, Huntington ND, Lim A, Yasuda E, Diehl SA, Scheeren FA, Ott M, et al. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated “human immune system” mice. PLoS One 2010; 5:5; http://dx.doi.org/10.1371/journal.pone.0013137; PMID: 20957227
   PubMed Web of Science ®Google Scholar
• Ippolito GC, Hoi KH, Reddy ST, Carroll SM, Ge X, Rogosch T, Zemlin M, Shultz LD, Ellington AD, Vandenberg CL, et al. Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS One 2012; 7:e35497; http://dx.doi.org/10.1371/journal.pone.0035497; PMID: 22558161
   PubMed Web of Science ®Google Scholar
• Kuruvilla JG, Troyer RM, Devi S, Akkina R. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology 2007; 369:143 - 52; http://dx.doi.org/10.1016/j.virol.2007.06.005; PMID: 17707071
   PubMed Web of Science ®Google Scholar
• Seung E, Tager AM. Humoral immunity in humanized mice: a work in progress. J Infect Dis 2013; 208:Suppl 2 S155 - 9; http://dx.doi.org/10.1093/infdis/jit448; PMID: 24151323
   PubMedGoogle Scholar
• Karpas A, Dremucheva A, Czepulkowski BH. A human myeloma cell line suitable for the generation of human monoclonal antibodies. Proc Natl Acad Sci U S A 2001; 98:1799 - 804; http://dx.doi.org/10.1073/pnas.98.4.1799; PMID: 11172031
   PubMed Web of Science ®Google Scholar
• Schuster U, Büttner R, Hofstädter F, Knüchel R. A heterologous in vitro coculture system to study interaction between human bladder cancer cells and fibroblasts. J Urol 1994; 151:1707 - 11; PMID: 8189601
   PubMed Web of Science ®Google Scholar